Ravelcare BSE SME

Ravelcare SME IPO

Listed

BSE SMEOpens 1 December 2025Closes 3 December 2025

Ravelcare Ltd., established in November 2018, is a digital-focused beauty and personal care (BPC) company offering a wide assortment of customised products across haircare, skincare, bodycare, and scalp care. The brand…

Show more
Price band
₹123 - ₹130
Issue size
₹22.88 Cr
Lot size
1,000 shares
Type
BSE SME
GMP
₹75 (+57.7%)
Est. listing
₹205
Est. profit / app
₹1,50,000
Retail quota
33.44%

Key ratios

As per RHP / filings
Face value
₹10
EPS
9.32
P/E ratio
13.95
RoNW
50.77%
ROE
68.04%
Advertisement

Timeline

IPO Opens

1 Dec

IPO Closes

3 Dec

Allotment

4 Dec

Listing

8 Dec

IPO Timeline & Listing Details

EventDate
IPO Open Date1 December 2025
IPO Close Date3 December 2025
Allotment Date4 December 2025
Listing Date8 December 2025

Investment Categories

CategoryLotsAmount
Individual
2₹2,60,000
SHNI (Min)
3₹3,90,000
SHNI (Max)
7₹9,10,000
BHNIAbove ₹10,00,000
8₹10,40,000

IPO Reservation Details

CategoryReservation
QIB (Qualified Institutional Buyer)47.25%
NII (Non-Institutional Investor)14.24%
SHNI (Small Non-Institutional Investor)7.29%
BHNI (Big Non-Institutional Investor)14.09%
Retail33.44%
Market Maker5.07%
Total100.00%

IPO Objectives

  • Marketing and advertisement expenses toward enhancing the awareness and visibility of the brand (₹11.50 Cr).
  • Setting up a new manufacturing facility located at Mauje-Peth in Amravati (“Proposed facility”) (₹7.84 Cr).
  • General Corporate Purposes.

Strengths

  • The company uses a Digital-First D2C Model with strong penetration across its own website, major e-commerce platforms (Amazon, Flipkart), and quick-commerce channels (Blinkit).
  • It has an Innovation-Led Approach, offering a wide assortment of customized products based on digital consultations and data-driven R&D.
  • The business demonstrates exceptional operational efficiency with high return ratios: an ROE of 68.04% and RoNW of 50.77% in FY25.
  • IPO proceeds are strategically allocated for substantial brand marketing and setting up a new integrated manufacturing facility, which will reduce third-party reliance.
  • The company maintains a financially stable position with a negligible debt-to-equity ratio of 0.04 in FY25.

Weaknesses

  • It faces intense competition in the highly saturated D2C beauty and personal care (BPC) market from both established FMCG giants and other digital-first brands.
  • The High Customer Acquisition Cost (CAC) is evident by the large fund allocation to marketing (₹11.50 Cr), highlighting the expense required to acquire and retain digital customers.
  • The current reliance on contract manufacturing poses risks to supply chain quality and consistency until the new in-house facility is fully operational.
  • The static revenue growth (14% between FY24 and FY25) indicates potential challenges in scaling the top line despite high margins.
  • As an SME listing, the stock may face lower liquidity and higher price volatility post-listing.
Advertisement

Financial Performance

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Assets (₹ Cr.)15.6811.638.031.74
Revenue (₹ Cr.)14.4425.322.283.49
PAT (₹ Cr.)3.25.265.020.41
Net Worth (₹ Cr.)13.5510.355.10.07

Peer Comparison

CompanyP/B RatioP/E RatioRONW (%)Net Worth (₹ Cr.)

Subscription Details

Daily Bids Status

CategoryDay 1Day 2Day 3
QIB3.52x6.86x155.91x
NII25.81x148.16x752.16x
S-HNI23.44x130.48x505.5x
B-HNI27.03x157.31x879.74x
RII17.89x95.47x463.13x
Total15.5x81.55x437.6x

Overall Subscription Statistics

CategoryShares OfferedShares BidBid Amount (₹ Cr)
QIB3,51,0005,47,25,000711.42
NII2,64,00019,85,70,0002,581.41
Small NII90,0004,54,95,000591.43
Big NII1,74,00015,30,75,0001,989.98
RII6,20,00028,71,38,0003,732.79
Total12,35,00054,04,33,0007,025.63
Advertisement

Company Details

  • Ravelcare Ltd.
  • Off-126, Neo Corporate Plaza Cabin B, Ramchandra Lane Extension Malad, Mumbai, Malad, Maharashtra-400064
  • +91 87792 06822
  • pragya@ravelcare.com
  • http://www.ravelcare.com/

Registrar Details

Frequently Asked Questions

What is the business model of Ravelcare Limited?
Ravelcare operates on a D2C (Direct-to-Consumer) model, selling customized beauty and personal care products directly through its e-commerce website and platforms like Amazon and Myntra, focusing on hair, skin, and body care solutions.
When will the Ravelcare IPO open for subscription?
The Ravelcare IPO opens for subscription on December 1, 2025, and closes on December 3, 2025.
What is the IPO price band and market lot for Ravelcare?
The price band is set between ₹123.00 to ₹130.00 per share. Retail investors must apply for a minimum market lot of 1,000 shares.
What are the main objectives of the Ravelcare IPO?
The primary objectives are funding brand marketing and advertising activities (₹11.50 Cr) and setting up a new integrated manufacturing facility (₹7.84 Cr) in Amravati, Maharashtra.
What are the key financial strengths of Ravelcare?
Ravelcare achieved a high RoNW of 50.77% and a PAT margin of 20.79% in FY25, along with having a negligible debt-to-equity ratio of 0.04.
Which stock exchange will list the Ravelcare IPO?
The Ravelcare IPO is scheduled to list on the BSE SME exchange, with the tentative listing date being December 8, 2025.

Ravelcare SME IPO News & Updates

Follow the latest updates for Ravelcare SME IPO, including grey market moves and allotment news.

Ravelcare SME IPO IPO Pages

Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.

Sources

We match Ravelcare SME IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • Kfin Technologies Ltd.Official site to check allotment status for this IPO

Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.

Loading comments...